Приложение Г2. Расшифровка примечаний
…** – препарат входит в перечень жизненно необходимых и важнейших лекарственных препаратов (Распоряжение Правительства РФ от 12.10.2019 № 2406-р «Об утверждении перечня жизненно необходимых и важнейших лекарственных препаратов на 2020 год, а также перечней лекарственных препаратов для медицинского применения и минимального ассортимента лекарственных препаратов, необходимых для оказания медицинской помощи»
# - применение off-label – вне зарегистрированных в инструкции лекарственного средства показаний осуществляется по решению врачебной комиссии, с разрешения Локального этического комитета медицинской организации (при наличии), с условием подписанного информированного согласия родителей (законного представителя) и пациента в возрасте старше 15 лет.
Список литературы
[1]Геппе Н. А., Розинова Н. Н., Волков И. К., Мизерницкий Ю. Л. Рабочая классификация основных клинических форм бронхолегочных заболеваний у детей // ПМ. 2010. №45.
[2]Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace
SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT, «Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases
Society and the Infectious Diseases Society of America.,» Clin Infect Dis, № 53(7), pp. 61730, Oct 2011.
[3]Pocket book of hospital care for children: Second edition: Guidelines for the management of common childhood illnesses. WHO, 2013.
[4]Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, et al., «Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gramnegative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003,» Pediatr Infect Dis J., № 24(7), pp. 635-9, Jul 2005.
[5]Mishaan AM, Mason EO Jr, Martinez-Aguilar G, Hammerman W, Propst JJ, Lupski JR, et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar. 24(3):201-6.
[6]Katz B, Patel P, Duffy L, Schelonka RL, Dimmitt RA, Waites KB. Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol. 2005 Sep. 43(9):4852-4.
[7]Global Health Observatory. Proportions of child death by cause. (http://www.who.int/gho/child_health/en/index.html), WHO, Geneva Accessed on 24 July 2014.
[8]Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004 Apr. 113(4):701-7.
[9]Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, Barral A, et al. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J. 2008 Oct. 27(10):939-41.
[10]American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedules--United States, 2009. Pediatrics. 2009 Jan. 123(1):189-90.
[11]Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004 Sep 1. 39(5):681-6.
[12]Tajima T, Nakayama E, Kondo Y, Hirai F, Ito H, Iitsuka T, et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother. 2006 Dec. 12(6):372-9.
[13]Лазарева М.А., Куличенко Т.В., Алябьева Н.М. и др. Носоглоточное носительство Streptococcus pneumoniae у воспитанников детских домов, дошкольных учреждений и неорганизованных детей младше 5 лет. // Вопросы современной педиатр.-2015. Т. 14.
-№2- С.246-255.
[14]Stratchounski L. S., Kretchikova O. I., Kozlov R. S. Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia. Pediatr. Infect. Dis. J. 2000; 19: 196–200.
[15]Stratchounski L. S., Kozlov R. S., Appelbaum P. C., Kretchikova O. I., Kosowska-Shick K.,
«Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicenter study. Clin. Microbiol. Infect. 2006; 12: 853–866».
[16]Козлов Р. С., Сивая О.В., Кречикова О.И. и др. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999-2009 гг // Клин. Микроб. и Антимик. Химиотер. 2010. №12. C. 329-341.
[17]Лазарева М.А. Этиологическая роль Streptococcus pneumoniae при респираторных инфекциях, его носительство и чувствительность к антибиотикам у детей младшего возраста.: дис. … канд. мед. наук: — М., 2015. — 143 с..
[18]Dagan R., Givon-Lavi N., Leibovitz E. et al. Introduction and proliferation of multidrugresistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population // J. Infect. Dis. 2009. V. 199. P. 776-785..
[19]Tatochenko V, Sidorenko S, Namazova-Baranova L. et al., «Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program // Expert. Rev. Vaccines. 2014. V. 13: P. 257-264.».
[20]Козлов Р.С., Кречикова О.И., Муравьев А.А. и другие (2013). Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (Papirus)., «Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клиническая микробиология и антимикробная химиотерапия, 15 (4), 246-260».
[21]Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004
Dec. 82(12):895-903.
[22]Заболеваемость населения России в 2000-2009 гг. Статистические материалы МЗСР РФ..
[23]Community acquired pneumonia in children: update 2011. British Thoracic Society. Community acquired pneumonia in children guideline group. Thorax 2011;66. Suppl.2; 927-928.
[24]Levels and trends in child mortality: Report 2014. United Nations Inter Agency Group for Child Mortality Estimation. UNICEF, WHO, The World Bank, United Nations Population Divisoin. New York, 2014.
[25]Revised WHO classification and treatment of childhood pneumonia at health faciclities: evidence summaries. WHO, 2014. http://www.who.int/maternal_child_adolescent.
[26]Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI. Application of the World Health Organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department. Pediatr Infect Dis J. 2012 Jun. 31(6):561-4. .
[27]Таточенко В.К. Болезни органов дыхания у детей. М. Педиатръ. 2012.
[28]Rambaud-Althaus C., Althaus F., Genton B., D’Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis 2015 Published Online March 11, 2015..
[29]Ginsburg AS, Lenahan JL, Izadnegahdar R, Ansermino JM. A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia. Am J Respir Crit Care Med. 2018 May 1;197(9):1116-1127.
[30]Neuman MI, Monuteaux MC, Scully KJ, Bachur RG: Prediction of pneumonia in a pediatric emergency department. Pediatrics 2011, 128(2):246-253.
[31]Таточенко В. К. Клинические рекомендации. Педиатрия (Пневмония у детей) / под ред. А. А. Баранова. М.: ГЭОТАР-Медиа, 2005. 28 с..
[32]Манеров Ф. К. Диагностика и терапия острой пневмонии у детей при разных вариантах течения. Дис. … д. м. н. Новокузнецк, 1990.
[33]Mcintosh K. Community-Acquired pneumonia in children // N Engl J Med. 2002; 346 (6): 429–437.
[34]Crawford S. E., Daum R. S. Bacterial pneumonia, lung abscess and empyema / Pediatric respiratory medicine / ed. Taussig L. M., Landau L. I. Mosby, Inc., 2008: 501–553.
[35]Goodman D, Crocker ME, Pervaiz F. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group.
Lancet Respir Med. 2019 Dec;7(12):1068-1083.
[36]Thomas J, Pociute A, Kevalas R, Malinauskas M, Jankauskaite L. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020 Jan 9;46(1):4..
[37]Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011 Oct.
[38]Bhuiyan MU, Blyth CC, West R. Combination of clinical symptoms and blood biomarkers can improve discrimination between between bacterial or viral community-acquired pneumonia in children. BMC Pulm Med. 2019 Apr 2;19(1):71.
[39]Iroh Tam PY, Bernstein E, Ma X, Ferrieri P. Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Hosp Pediatr. 2015 Jun;5(6):324-36..
[40]Eber E, Midulla F, eds. ERS handbook of paediatric respiratory medicine. Sheffield: European Respiratory Society, 2013: 719 p.
[41]Hosseini SM, Poorolajal J, Karami M, Ameri P. Prevalence of Nasopharyngeal Carriage of Streptococcus pneumonia in Iran: A Meta-Analysis. J Res Health Sci. 2015 Summer;15(3):141-6..
[42]Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10).
[43]de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet. 2020 Sep 12;396(10253):786-798. doi: 10.1016/S0140- 6736(20)31550-6. PMID: 32919518.
[44]Spuesens E.B., Fraaij P.L., Visser E.G. et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observa-tional study. PLoS Med. 2013; 10 (5): e1001444.
[45]Copete, A.R., Vera, C., Herrera, M. et al. Mycoplasma pneumoniae in children with and without community-acquired pneumonia. What do PCR and serology say? PIDJ 2020; 39 (7): E104-E108.
[46]Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12.
[47]Dean P, Florin TA. Factors Associated With Pneumonia Severity in Children: A Systematic